ArticleBMJ open2025

Neoadjuvant chemotherapy or chemoradiotherapy plus sintilimab versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a study protocol of a multicentre, randomised, controlled, phase III trial (SCIENCE study).

Wenwu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.